Cutting Scope 3 Emissions in Biologics Labs: A Case-Study with GSK

This case study between My Green Lab and GSK (or BMS if GSK unavailable) explores how leading biotech and pharma companies are tackling the high Scope 3 emissions inherent in biologics R&D and laboratory operations. Drawing on real-world implementations of the My Green Lab Certification program, it highlights practical strategies for reducing energy, water, and waste in biologics labs while achieving significant cost savings and supporting corporate net-zero commitments. The session will share concrete outcomes from certified labs, including scientist engagement, supply chain collaboration through the Converge program, and the role of sustainable lab practices in enabling more efficient biologics development.